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Epigenetic alterations mediate iPSC-induced normalization
of DNA repair gene expression and TNR stability in
Huntington’s disease cells
Peter A. Mollica1,2, Martina Zamponi1,3, John A. Reid1,3, Deepak K. Sharma1, Alyson E. White1, Roy C. Ogle1,
Robert D. Bruno1,*,‡ and Patrick C. Sachs1,*,‡
ABSTRACT
Huntington’s disease (HD) is a rare autosomal dominant
neurodegenerative disorder caused by a cytosine-adenine-guanine
(CAG) trinucleotide repeat (TNR) expansion within the HTT gene.
The mechanisms underlying HD-associated cellular dysfunction in
pluripotency and neurodevelopment are poorly understood. We
had previously identified downregulation of selected DNA repair
genes in HD fibroblasts relative to wild-type fibroblasts, as a result of
promoter hypermethylation. Here, we tested the hypothesis that
hypomethylation during cellular reprogramming to the induced
pluripotent stem cell (iPSC) state leads to upregulation of DNA
repair genes and stabilization of TNRs in HD cells. We sought to
determine how the HD TNR region is affected by global epigenetic
changes through cellular reprogramming and early
neurodifferentiation. We find that early stage HD-affected neural
stem cells (HD-NSCs) contain increased levels of global
5-hydroxymethylation (5-hmC) and normalized DNA repair gene
expression. We confirm TNR stability is induced in iPSCs, and
maintained in HD-NSCs. We also identify that upregulation of 5-hmC
increases ten-eleven translocation 1 and 2 (TET1/2) protein levels,
and show their knockdown leads to a corresponding decrease in the
expression of select DNA repair genes.We further confirm decreased
expression of TET1/2-regulating miR-29 family members in HD-
NSCs. Our findings demonstrate that mechanisms associated with
pluripotency induction lead to a recovery in the expression of select
DNA repair gene and stabilize pathogenic TNRs in HD.
KEY WORDS: Huntington’s disease, Ten-eleven translocation,
miR-29, Trinucleotide repeat, iPSC
INTRODUCTION
Huntington’s disease (HD) is a rare neurodegenerative disorder that
is caused by an expansion of cytosine-adenine-guanine (CAG)
trinucleotide repeats (TNR) in exon 1 of the HTT gene (MacDonald
et al., 1993). This pathogenic TNR region is prone to variable
instability in the body, as evidenced by somatic tissue mosaicism
and intergenerational differences during disease transmission
(Fortune et al., 2000; Langbehn et al., 2004, 2010; Ranen et al.,
1995). The mechanisms regulating HD TNR expansions within
somatic tissues and germinal cells are not comprehensively
understood.
Mutant huntingtin (mHtt) protein has extensive pathogenic
effects including transcription factor aggregation, mitochondrial
dysfunction, decreased efficacy of DNA damage repair activity and
an altered response to oxidative stress (Brustovetsky, 2015; Chang
et al., 2012; del Hoyo et al., 2006; Dunah et al., 2002; Glajch and
Sadri-Vakili, 2015; Jonson et al., 2013; Mann et al., 1990;
McQuade et al., 2014; Nucifora et al., 2001; Tsoi et al., 2012;
Zhai et al., 2005). Furthermore, recent evidence from our laboratory
and others demonstrates that the presence of mHtt also affects
various epigenetic mechanisms (Buckley et al., 2010; Mollica et al.,
2016; Suzuki and Bird, 2008). Specifically, we previously reported
that DNA methylation in HD patient-derived fibroblasts leads to
downregulation of a subset of DNA repair genes and TNR
instability (Mollica et al., 2016). These selected DNA repair
genes, APEX1, BRCA1, RPA1 and RPA3, are known effectors of
TNR stability (Andreoni et al., 2010; Beaver et al., 2015; Broderick
et al., 2010; Crespan et al., 2015; Li et al., 2014; Mason et al., 2014;
Spiro and McMurray, 2003). Furthermore, we also demonstrated
that inducing hypomethylation with a DNA methyltransferase
inhibitor resulted in TNR stabilization. These data identify potential
epigenetic involvement in HD that controls TNR stability and
genomic integrity. Furthermore, these data have potentially
important implications for mechanisms of genetic anticipation,
disease development and possible therapeutic treatments. However,
the application of these findings to developmental models and
disease relevant cells is of obvious interest.
Induced pluripotent stem cell (iPSC) technology is attractive, not
only for novel therapies, but also for generation of HD and other
neurodegenerative experimental models where access to disease-
specific cell types is not feasible (Choi et al., 2014; Hick et al., 2013;
Kaye and Finkbeiner, 2013; Lee and Huang, 2017; Nayler et al.,
2017; Nenasheva et al., 2016). One of the most recognized
characteristics of iPSCs is the global epigenetic changes involved in
reprogramming, as multiple studies have identified extensive
differential regulation of epigenetic elements and patterns (Carey
et al., 2011; Hewitt et al., 2011; Leung et al., 2014; Vaskova et al.,
2013). Of these epigenetic mechanisms, microRNAs such as miR-
29 family members have been shown to affect active demethylation
mechanisms in iPSCs due to their regulatory interactions with
members of the ten-eleven translocation (TET) protein family
(Morita et al., 2013; Zhang et al., 2013). The TET family proteins
actively catalyze the conversion of 5-methylcytosine (5-mC)Received 11 January 2018; Accepted 5 June 2018
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into 5-hydroxymethylcytosine (5-hmC), restructuring the DNA
methylation-based epigenetic landscape during the process of
acquiring pluripotency (Dawlaty et al., 2014; Hysolli et al., 2016;
Ito et al., 2010). Interestingly, miR-29 has also been reported to be
differentially expressed in primary HD cells in microRNA
expression screens (Johnson et al., 2008; Martí et al., 2010).
Furthermore, TET proteins, 5-mC and 5-hmC have emerged as
being involved in neurodegenerative diseases, such as Parkinson’s
disease, Alzheimer’s disease, amyotrophic lateral sclerosis, as well
as in HD (Al-Mahdawi et al., 2014; Buckley et al., 2010; Pan et al.,
2016; Rudenko et al., 2013; Santiago et al., 2014).
With this data taken together, we set out to investigate the effects
that epigenetic reconstruction, via reprogramming HD affected
fibroblasts to a pluripotent state and subsequent neural stem cell
(NSC) differentiation, would have on DNA repair gene expression
and TNR instability. We determine that, during reprogramming,
5-hMC levels are increased similarly in both wild-type and HD
iPSCs, but that 5-hMC remains significantly elevated in HD cells
during differentiation to neuronal stem cells. This increase
correlated with an increase in DNA repair gene expression and
TNR stability, consistent with our previous results. Finally, we
demonstrate that the increase in 5-hMC levels is likely due to an
increase in TET protein expression, mediated by decreased
expression of miR-29a/b in HD-NSCs. These data have important
implications for our understanding of disease progression, and the
mechanisms of TNR instability in HD.
RESULTS
HD iPSCs and NSCs show increased DNA repair gene
expression
We previously identified downregulated gene expression of the
DNA repair genes APEX1, BRCA1, RPA1 and RPA3 in multiple HD
fibroblast cell lines derived from patients, and that their expression
could be recovered upon forced hypomethylation (Mollica et al.,
2016). Owing to the global epigenetic restructuring that occurs
during iPSC reprogramming, we sought to determine how those
epigenetic changes would affect DNA repair gene expression in HD
cells. To accomplish this, wild-type (Wt) and HD-affected cell lines
were reprogrammed to iPSCs (Fig. S1) and then differentiated into
NSCs (Fig. S2). At population doubling (PD) 10 of each cell state
(iPSC and NSC), total RNA was collected to determine the gene
expression of APEX1, BRCA1, RPA1 and RPA3. Relative to their
expression at the pre-reprogrammed fibroblast state, both HD-iPSCs
and HD-NSCs showed increased expression of all repair genes
analyzed, while expression in Wt cells remained constant (Fig. 1).
Furthermore, no significant differences in expression were observed
for any of the genes in HD-iPSCs or HD-NSCs relative to WT-
iPSCs and WT-NSCs, respectively. Therefore, the reprogramming
process rescues the expression of DNA repair genes APEX1,
BRCA1, RPA1 and RPA3 in HD cells, and the rescued phenotype
persists through NSC differentiation.
TNR regions of HTT gene remain stable after pluripotency
induction and during early-stage neuronal differentiation
With the witnessed normalization of DNA repair gene expression in
HD-affected iPSCs and NSCs, we next wanted to determine how
changes in differentiation status affected the pathogenic repeat
expansion in the HTT gene. Genomic DNA samples were collected
from the HD1 fibroblast line at PD 12 and 20, and HD2 fibroblast
line at PD 8 and 16, as well as from iPSC-HD1, iPSC-HD2 cells,
and HD1-NSCs and HD2-NSCs at PD 0 and PD 20 for TNR
expansion analysis. By performing capillary electrophoresis-based
fragment analysis, it was revealed that HD1 fibroblasts contained
18/43 CAG repeats at PD 12 and 18/44 CAG repeats at PD 20. HD2
fibroblasts contained 17/41 CAG repeats at PD 8 and 17/42 at PD
16, within the HTT gene (Fig. 2A,B; Fig. S3C,D). HD1 and HD2
continued to maintain the same size TNR region immediately
following iPSC reprogramming, and throughout 20 PDs post-
reprogramming with repeats of 18/44 and 17/42, respectively
(Fig. 2A,B; Fig. S3A,B). Fragment analysis of HD1-NSC and HD2-
Fig. 1. HD-iPSCs and -NSCs show recovery of expression of select DNA
repair genes to Wt levels. qRT-PCR for APEX1, BRCA1, RPA1 and RPA3
mRNA levels through NSC differentiation. Gene expression for all DNA repair
genes was downregulated in HD fibroblasts relative to those in Wt. During
reprogramming and after NSC differentiation all repair genes were upregulated
to Wt levels. Fold change is relative to the average mean expression of two
native wild-type cell lines. Results are mean±s.d. for each replicate. All
experiments were conducted in triplicate and compared by a one-way ANOVA
with Dunnett’s post hoc (**P<0.01).
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NSCs genomic (g)DNA at PD 0 and 20 also revealed no change had
occurred in the number of CAG repeats from their iPSC state
(Fig. 2A,B). These data on TNR region stability from iPSC
reprogramming to neural induction are in direct contrast to our
published findings in the HD fibroblast lines, which demonstrate a
rapid expansion within 8 PDs (Mollica et al., 2016). Thus, we
conclude that inherent features of the reprogramming process result
in the stabilization of the pathological TNR repeat region within the
HTT gene. Interestingly, upon successful neural induction into
NSCs, both HD cell lines maintained the initial CAG repeat lengths
originally seen in their fibroblast state, indicating a retained TNR
stabilization (Fig. 2).
HD-affected NSCs have increased global 5-hmC
The epigenetic landscape has been shown to shift dramatically
during iPSC reprogramming. One of the novel epigenetic
mechanisms reportedly involved in reprogramming is the
increased presence of 5-hydroxymethylcytosine (5-hmC)
production. As we witnessed an increase in select DNA repair
gene expression, which coincided with TNR stability, we
hypothesized that epigenetic mechanisms related to gene
activation had occurred during reprogramming and were
maintained during differentiation. More so, following reports of
differential presence of 5-hmC in HD cells, we identified this as a
possible mechanism for our observed results (Glajch and Sadri-
Vakili, 2015; Lee et al., 2013; Wang et al., 2013). We analyzed
gDNA samples extracted from all diseased and unaffected
fibroblasts, iPSCs and NSCs (collected at PD 20) to determine the
global percentages of 5-hmC presence through sandwich-based
ELISA (Fig. 3A). We found that the pre-reprogrammed HD
fibroblasts did not show significant differences in the percentage
of global 5-hmC in comparison to the pre-reprogrammed Wt
fibroblast cells. In addition, there was no significant difference in
the percentage 5-hmC presence after induction of pluripotency
of diseased versus unaffected cells. However, we did witness
substantial increases in 5-hmC presence in all iPSCs when compared
Fig. 2. HD-affected iPSC and NSCs
show trinucleotide repeat stability
through 20 PDs. (A) Fragment
analysis of gDNA samples extracted
from patient-derived HD fibroblast
sample HD1 shows that the HTT
pathogenic allele containing 43 CAG
trinucleotide repeats at PD 12 and then
44 CAG repeats immediately prior to
reprogramming (row 1). Analysis of
successfully reprogrammed HD1-iPSC
samples show that the 44 CAG repeats
are maintained from PD 0 (row 2) to
PD 20 (row 3). Immediately after NSC
differentiation (row 4), and 20 PD later
(row 5), gDNA fragment analysis shows
44 CAG repeats. (B) TNR analysis of
HD2 fibroblasts at PD 8 shows that
there are 41 CAG repeats and then
42 CAG repeats at PD 20, prior to
reprogramming (row 1). Immediately
following iPSC reprogramming (row 2)
and 20 population doublings later (row
3), the number of CAG repeats remain
at 42. Following NSC differentiation
(row 4) and successive passaging for
20 PDs (row 5), the TNR region shows
stability with 42 CAG repeats.
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to their fibroblast state, verifying that methylation patterning undergoes
extensive changes during cellular reprogramming. Interestingly,
the percentage levels of global 5-hmC presence in NSC-HD1 and
NSC-HD2 were significantly increased relative to the control NSCs.
gDNA samples from NSC-HD1 and NSC-HD2 cells contained
0.066% and 0.059% 5-hmC residues, respectively, relative to the
Fig. 3. Altered 5-hmC and DNMT protein expression in HD-
NSCs. (A) Global 5-hmC levels were analyzed for each cell
type/state. HD1 and HD2 had statistically significant increases
in 5-hmC levels as compared to Wt controls. Results are mean
±s.d. for the percentage of 5-hmC between each of the six
gDNA samples. (B) qRT-PCR analysis of DMNT1, DMNT3A
and DMNT3B revealed significantly greater levels of DNMT1
and DNMT3B mRNA levels in HD1 and HD2 fibroblasts as
compared to Wt controls. (C) When reprogrammed into iPSCs,
HD1 and HD2 cells had no significant differences in DNMT
mRNA levels compared to controls. (D) Upon differentiation to
NSCs, significant differences in DNMT expression were again
observed in HD cells compared to Wt controls. Results are the
mean±s.d. fold regulation of each sample. All experiments
were conducted in triplicate and compared with a one-way
ANOVA with Dunnett’s post hoc (*P<0.05, **P<0.01,
***P<0.001).
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mean of the Wt samples, which contained 0.040% (Fig. 3A). These
data reveal that the epigenetic landscape is altered during
neurodevelopment in response to the presence of mHtt.
Differential expression of DNMT proteins in HD-affected
iPSCs and NSCs
We had previously reported HD-specific differential methylation
patterns in the promoter regions of the DNA repair genes (Mollica
et al., 2016). While the increased presence of 5-hmC in HD-NSCs is
indicative of active demethylation, we next sought to characterize
the status of active methylation across each cell state. Here, we
evaluated gene expression of DNMT1, DNMT3A and DNMT3B, for
which the encoded proteins are involved in active methylation of
newly synthesized DNA. In the native, fibroblast cell state, both
DNMT1 and DNMT3B showed statistically significant upregulation
in both HD samples as compared to Wt (Fig. 3B), consistent with
increased methylation at select promoter sites, as we have
previously shown (Mollica et al., 2016). Expression analysis of
Wt- and HD-iPSCs revealed no statistical difference in expression
between the groups, indicating that, during reprogramming, the
levels of these genes return to normal (Fig. 3C). Furthermore,
analysis of DNMT genes in all NSC lines showed that gene
expression of DNMT3A was slightly upregulated in both HD
samples (Fig. 3D). Furthermore, NSC-HD1 cells showed increased
expression ofDNMT1 andDNMT3B. These data suggest that during
pluripotency induction, the expression of factors involved in active
DNA methylation is corrected in HD cells. However, although
HD-NSCs begin to exhibit dysregulation of components involved
in epigenetic regulation, this data reveals that dysregulation is
occurring in different components (DNMT3A), while the native
HD fibroblasts showed no dysregulation in DNMT3A. This
upregulation of DNMT3A may be counterbalanced, however, by
an increase in active demethylation as indicated by the increased
levels of 5-hmC shown above (Fig. 3A).
Dysregulated TET1/2 expression in HD-affected neural
stem cells
Recently, studies have demonstrated that 5-mC can be actively
converted into 5-hmC by the ten-eleven translocation (TET) family
proteins (Zhang et al., 2013). Moreover, evidence is mounting for
the critical involvement of TET proteins in maintaining enriched
levels of 5-hmC in iPSCs and neural cell types (Ito et al., 2010; Koh
et al., 2011; Kriaucionis and Heintz, 2009). Thus, we next wanted to
confirm whether the increased 5-hmC presence in HD-NSC lines
was due to alterations of TET family proteins. We conducted gene
expression analysis of pre-reprogrammed fibroblasts, iPSC and
NSC cell types from unaffected and HD patients for TET1 and
TET2. HD-affected fibroblasts and iPSCs, showed no TET1 or
TET2 gene dysregulation when compared to expression levels in Wt
controls (Fig. 4A, left and middle). However, NSC-HD1 and NSC-
HD2 lines showed significant increases in TET1 expression, with
NSC-HD1 also having significant upregulation of TET2 (Fig. 4A,
right). By determining the relative fluorescence intensity in
immunocytochemistry experiments, we evaluated the relative
presence of both proteins using dual-staining methods (Fig. 4B).
Fluorescence intensity calculations showed increased protein
expression of TET1 in both HD-NSC samples (Fig. 4C, top) and
increased protein expression of TET2 in NSC-HD1 (Fig. 4C
bottom), normalized to unaffected NSC samples. Differences in
TET1 and TET2 protein expression were further confirmed in
western blotting and spot densitometry experiments (Fig. 4D). This
corroborates our immunocytochemistry analysis, authenticating
TET1 upregulation in NSCs affected by HD. To verify a link
between TET expression and expression of select DNA repair
genes, we evaluated the expression of APEX1, BRCA1, RPA1 and
RPA3 on NSC-HD2 cells when siRNA targeting TET1 and TET2
were introduced. Introduction of siRNA targeting TET1 and TET2
led to decreased expression of endogenous levels of available TET1
and TET2 mRNA (Fig. 5A). Furthermore, gene expression analysis
revealed significantly decreased levels of RPA1 in response to
siRNA targeting TET2, and APEX1 and RPA3 when cells were
treated with both siRNA targeting TET1 and TET2 (Fig. 5B). This
data supports a link between APEX1 and RPA1 expression and
TET1/2 levels in HD-affected neural stem cells. Furthermore, these
data together explain the relative increased levels of 5-hmC
presence seen in HD-affected NSCs, and is consistent with the
interpretation that upregulation in components of methylation
pathways are a proportional response to mobilized active
demethylation.
HD-affected NSCs exhibit decreased expression of
miR-29a/b
Since the verification of TET family proteins, and mechanisms with
the capability to actively demethylate DNA, there has been
extensive investigation into its regulation, especially concerning
its involvement in mammalian development, cancer and stem cell
self-renewal (Dawlaty et al., 2014; Ito et al., 2010; Kinney and
Pradhan, 2013). One of the most recognized regulators of TET1/2 is
the microRNA pathway, specifically the miR-29 miRNA family
(miR-29a, miR-29b and miR-29c) (Morita et al., 2013).
Importantly, there have been previous reports that miR-29 family
members are dysregulated in HD, including in HD neuronal cell
types (Johnson et al., 2008; Martí et al., 2010). As this presents a
clear explanation of the changes we were witnessing, here we
wanted to see whether miR-29 dysregulation was related to the
upregulation of TET in HD. Quantitative (q)PCR of HD-affected
fibroblasts confirmed previous findings of dysregulation in the
members of the miR-29 family, relative to wild-type levels
(Fig. 5C). However, expression of miR-29a, -29b and -29c was
not changed in HD-iPSCs when compared to the levels in Wt iPSCs
(Fig. 5D). Strikingly, HD-NSCs showed significant decreases in
expression of miR-29a and miR-29b (Fig. 5E). These data, taken
together, identify the miR-29 epigenetic regulatory pathway as
being affected by early-stage HD during neurodevelopment.
Moreover, this expression of miR-29 members in HD fibroblasts
and HD NSCs fits the expression pattern of TET proteins, thereby
providing a possible mechanism for the increased 5-hmC presence
witnessed in HD-NSCs.
DISCUSSION
Although it is clear that TNR expansions within the HTT gene are a
hallmark of HD, it remains unclear why unregulated expansions
occur throughout the lifespan of HD patients, but do not occur
during embryonic development (Kovtun et al., 2004; Mangiarini
et al., 1997). As TNR expansions are associated with the age of
onset and severity of the disease, comprehensive understanding of
the process could lead to therapeutic interventions aimed at
stabilizing TNR regions, delaying the onset of the disease and
minimizing genetic anticipation in subsequent generations.
While the comprehensive mechanism of pathological HD TNR
instability is poorly understood, it is agreed that endogenous DNA
repair mechanisms are involved. We previously identified APEX1,
BRCA1, RPA1 and RPA3 as being consistently downregulated
across multiple HD lines, and demonstrated that their
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downregulation was epigenetically mediated (Mollica et al., 2016).
These genes have also previously been identified as effectors of
TNR instability (Andreoni et al., 2010; Beaver et al., 2015; Li et al.,
2014; Mason et al., 2014). APEX1 in particular has been shown to
be required for the maintenance of TNRs (Beaver et al., 2015).
Furthermore, all three of these genes are involved in base excision
repair, highlighting the potential for a collective aberrant effect on
genome instability, as witnessed in other trinucleotide repeat
diseases (Goula and Merienne, 2013; Liu and Wilson, 2012). In
addition, it should be noted that as TNR stability/instability is a
function of DNA repair, and therefore when measured with TP-PCR
and capillary electrophoresis, can act as a surrogate marker of repair
processes (Dion, 2014; Dragileva et al., 2009; Goula et al., 2009;
Zhao and Usdin, 2015). Therefore, the rescue of expression of this
subset of DNA repair genes through cellular reprogramming is
significant, and consistent with our previous findings that
hypomethylation leads to stabilization of TNRs (Mollica et al.,
2016).
Here we propose a model in which mHtt interferes with normal
epigenetic regulation, leading to downregulation of key DNA repair
Fig. 4. HD-affected neural stem cells show upregulated TET protein expression. (A) Gene expression analysis of TET1 and TET2 in HD and Wt fibroblasts
(left), HD and Wt iPSCs (middle), and HD and Wt NSCs (right) reveal that there is a statistically significant upregulation of TET1 and TET2 in the NSC state.
(B) Immunofluorescence staining confirmed the increase in TET1 and TET2 in HD-NSCs. TET1 protein expression (top panels) shown in green and TET2 protein
expression (middle panels) shown in red. All cells were counterstained with DAPI (bottom panels). (C) Quantification of fluorescent images shown in B.
(D) Western blot and spot densitometry quantification of NSC samples also confirmed upregulation of TET1 and TET2. Results are the mean±s.d. for each
replicate. All experiments were conducted in triplicate and compared with a one-way ANOVA with Tukey post-hoc (*P<0.05).
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proteins, which, in turn, promotes TNR expansions. Our previous
data identified a potential link between methylation, expression of
select DNA repair genes and TNR stability in HD patient-derived
fibroblasts (Mollica et al., 2016). With the data presented here, we
show that mechanisms involved in pluripotency reprogramming
correct these previously reported deficiencies in DNA repair
genes, corresponding with an increase in TNR stabilization. The
stabilization of the iPSC TNR regions might be mediated by
the global shifts in DNA methylation patterns seen during
reprogramming, mimicking our findings in HD fibroblasts treated
with a DNMT inhibitor (Mollica et al., 2016). We were surprised to
find no differences in DNA repair gene expression between Wt and
HD cells following NSC induction; however, consistent with our
model, TNR regions of HD-affected NSCs remained stable.
Genome-wide loss of 5-hmC in HD, and a resultant
hypermethylation has been previously reported and extensively
implicated in dysfunctional neurogenesis, neuronal function and
survival (Al-Mahdawi et al., 2014; Wang et al., 2013). However,
our findings demonstrate that 5-hmC levels were either normal or
increased in HD cells following reprogramming. In addition, we
show that both DNMT1 and DNMT3B are upregulated in the HD
fibroblast cells and HD-NSCs. This suggests that DNMTexpression
seems to be balanced by an increase in 5-hmC and TET levels in
HD-iPSC and HD-NSCs. This supports the notion that the
pluripotent state has a protective effect on HD-derived neuronal
cells. Other findings bolster this claim, such as the finding that
transplanted human HD-iPSC into the striatum of mice show
delayed HD phenotypes, indicating mechanisms altered in
reprogramming affect symptom presentation (Jeon et al., 2014).
This suggests that the increased active demethylation processes help
maintain normalized DNA repair gene expression and TNR
stability. While the decline of HD-iPSC-derived cells would be
expected to start upon differentiation, ultimately leading to a loss in
DNA repair gene expression and TNR stability, it is possible that
years of expression of the mHtt protein is required for cumulative
epigenetic effects to occur following iPSC reprogramming. Finally,
we also implicate miRNA-29 dysregulation as a possible
mechanistic link resulting in the epigenetic shifts seen during the
iPSC to NSC transition. miR-29 targets TET1 and has been
previously indicated as a possible regulatory protein in HD
(Johnson et al., 2008; Morita et al., 2013; Roshan et al., 2014).
Furthermore, through partial knockdown of TET1 and TET2, we
show that these proteins have a direct link to DNA repair gene
expression of APEX1 and RPA3, necessary components of the
base excision repair pathway, which has been implicated as an
effector of TNR instability. We also recognize that the observed
increase in 5-hmC presence may either be directly related to mHtt
interactions, and, therefore, deleterious over time, or may be a
protective countermeasure in response to increased methylation
(5-mC) accumulation (Ng et al., 2013). While this remains
speculation, it is a critical area in need of future study.
In the short time iPSC reprogramming has been available,
research using HD-iPSCs has recognized that pluripotent cells
affected by HD show differentially expressed proteins and also
that HD-iPSC models maintain the disease phenotype after
differentiation and transplantation. These data support our
findings that TNR regions are stabilized during pluripotency and
early differentiation (Chae et al., 2012; HD iPSC Consortium, 2012;
Fig. 5. TET knockdown decreases expression of select DNA repair genes, and TET-regulating miR-29a/b/c are differentially expressed in HD
fibroblasts and HD-NSCs. (A) qRT-PCR confirmation of siRNA-targeted knockdown of TET1 and TET2mRNA in HD-NSCs. (B) The DNA repair genes APEX1,
RPA1 andRPA3 show downregulation in response to combined partial knockdowns of TET1 and TET2 in NSC-HD2 cells. (C) Expression analysis demonstrating
significantly increased expression of miR-29a/b/c in HD fibroblasts compared to controls. (D) No significant differences in miR-29a/b/c levels were seen
in HD-iPSC lines. (E) HD-NSCs expressed significantly less miR-29a/b than Wt controls. Results are the mean±s.d. for each replicate. All experiments were
conducted in triplicate and compared with a one-way ANOVA with Dunnett’s post hoc (*P<0.05; **P<0.01).
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Jeon et al., 2014, 2012; Juopperi et al., 2012). These data also give
some indication that the in vitro methods we employed to study
these TNR dynamics have some translatable effect. These data
combined provide insight into the mechanism behind adult somatic
instability, and the resulting genetic anticipation. Furthermore, our
data demonstrate a possible mechanism of pluripotency-induced
normalization of cellular function and TNR stability and the
subsequent contraction bias witnessed in embryonic development.
MATERIALS AND METHODS
Cell lines and culture
Two previously confirmed HD fibroblast cell lines (GM02191 and
GM04022) were purchased from Coriell Cell Repositories (Camden, NJ)
at early passages (3 and 4, respectively). Two Wt breast-derived adipose
stem cells (bASC3 and bASC8) were previously isolated (Sachs et al., 2012;
Zhao et al., 2012). HD fibroblast and bASC lines were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) containing Glutamax
(Gibco, Gaithersburg, MD), supplemented with 10% premium fetal bovine
serum (Life Technologies) and 1% antibiotic-antimycotic (100×) (ABAM;
Life Technologies). Medium was replenished between 72 and 96 h after
seeding. Cells were cultured in a T-75 flask and passaged upon reaching
75–85% confluency using TrypLE Express (Gibco) following the
manufacturer’s protocol. Cell lines were maintained at 37°C in a
humidified incubator with 5.0% CO2. For simplicity, in the rest of the
paper, GM04022 is denoted HD1, GM02191 is denoted HD2, bASC3 is
denoted Wt1, and bASC8 is denoted Wt2.
iPSC reprogramming
To generate stable pluripotent cells, on day 0, 2.5×105–3×105 cells were
infected using Sendai viral vectors expressing KOS (Klf4, Oct3/4 and
Sox2), c-Myc, and Klf4 using the CytoTune™ –iPS 2.0 Sendai
Reprogramming kit (Life Technologies, Carlsbad, CA). Cells were
transformed according to the manufacturer’s protocol, and lot
specification (Lot# L2120009) of Sendai viral components, using a
multiplicity of infection (MOI) of 5:5:3. On day 7 post transduction, cells
were plated onto irradiated murine embryonic fibroblasts (iMEFs)
(Globalstem; Gaithersburg, MD). After confirmation of TRA-1-81-
positive pluripotent cells (with antibody from Stemgent®; Lexington,
MA), colonies were manually split and passaged for expansion. Upon initial
expansion, all iPSC lines were adapted to a feeder-independent protocol
using plates coated with Geltrex® LDEV-free reduced growth factor
basement membrane Matrix (Life Technologies, Carlsbad, CA) at a
concentration of 140–150 µg/ml and were continuously cultured in
mTeSR™1 (Stemcell™ Technologies, Vancouver, Canada) for the
remainder of our experiments. iPSC lines adapted to mTeSR were
passaged and split at ratios of 1:6 to 1:9 using 1 U/ml dispase (Stemcell™
Technologies). Media was replenished on all pluripotent cell lines
every 24 h.
After pluripotent transformed colonies were observed, a live-cell
pluripotency stem cell marker, anti-TRA-1-81 antibody conjugated to
Alexa Fluor 488 (1:200, Stemgent, Lexington, MA), was added to cultures
and allowed to incubate for 30 min at 37°C, to identify pluripotent-positive
colonies. After live-stain confirmation, TRA-1-81-positive colonies were
manually picked off and plated onto murine embryonic fibroblasts after
28 days. Following expansion of TRA-1-81 colonies, alkaline phosphatase
(AP) expression was detected by using alkaline phosphatase kit II
(Stemgent®; Lexington, MA) according to the recommended protocol.
Furthermore, subsets of each pluripotent cell line were analyzed for gene
expression of pluripotency markers using qPCR (see section on gene
expression below) and a teratoma assay (as described below).
Teratoma assay
The tri-lineage differentiation potential of iPSCs were determined by a
modified teratoma assay. iPSC colonies were manually excised from culture
dishes and injected into the epithelial divested mammary fat-pads of
3-week-old female Nu/Nu mice (Charles River Laboratories) using surgical
procedures previously described (Boulanger et al., 2013, 2012; Bruno et al.,
2014, 2017; Bussard et al., 2010; Zhao et al., 2012). Teratomas were excised
8 weeks post injection, fixed in 10% neutral-buffered formalin (NBF) for
24 h, and then paraffin embedded for immunohistological characterization
with H&E. All mice were housed in an Association for Assessment and
Accreditation Laboratory Animal Care (AALAC)-accredited facility. All
procedures were approved by the Old Dominion University Institutional
Animal Care and Use Committee (IACUC).
NSC induction and characterization
iPSCs underwent NSC induction using STEMdiff Neural Induction
Medium (NIM) (Stemcell™ Technologies) and AggreWell™ 800
(Stemcell™ Technologies) according to the manufacturer’s protocol.
Briefly, 3.0×106 cells were put into single-cell suspension using dispase,
washed with NIM, and plated into a single well of the AggreWell™ 800
plate with NIM supplemented with 10 µM Y-27632 (Sigma Aldrich, St
Louis, MO). Cells were centrifuged at 100 g for 3 min and then incubated at
37°C in a humidified incubator containing 5.0% CO2. Partial medium
changes were conducted daily for 4 days. On day 5, embryoid bodies were
removed and filtered through a 40-µm strainer and plated onto a Geltrex®-
coated six-well plate in NIM. Daily medium changes were conducted from
days 6–11. On day 12, neural rosettes were gently dislodged using
STEMdiff™ Neural Rosette Selection Reagent (Stemcell™ Technologies)
and expanded on Geltrex-coated dishes. Full medium changes occurred for
the remainder of the 19-day differentiation. Following characterization (see
section on confirmation of neural stem cell differentiation below), NSCs
were maintained in StemPro® NSC SFM medium supplemented with
10 ng/ml bFGF, 10 ng/ml EGF, and 1× ABAM, and medium was
replenished every other day.
Following neural stem cell differentiation, 5.0×104 cells were plated onto
Geltrex-coated slides (1:50) and allowed to attach for 48 h. Cells were fixed
with 10% NBF for 1 h, permeabilized with 100% ice-cold methanol for
15 min at −20°C, and blocked with 10% goat serum in Tris-buffered saline
at room temperature for 1 h. Samples were probed with antibodies for nestin
(10C2, 1:100, Thermo Fisher Scientific), PAX6 (13B10-1A10, 1:200,
Thermo Fisher Scientific), SOX1 (ab87775, 1:200, Abcam) and SOX2
(PA1-094, 1:100, Thermo Fisher Scientific). Mouse antibodies were
detected with goat anti-mouse-IgG antibody conjugated to Alexa Fluor
488, and rabbit antibodies were detected with goat anti-rabbit-IgG antibody
conjugated to Alexa Fluor 568 (Thermo Fisher Scientific). All samples were
counterstained with DAPI.
Nucleic acid extraction and gene expression
Total RNAwas isolated from cells upon reaching 70–85% confluence with
Trizol (Thermo Fisher Scientific) following the recommended protocol.
Approximately 3.0–7.5×105 cells were used for all genomic DNA (gDNA)
extractions with a DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany).
Gene expression analysis was performed using TaqMan® gene expression
assays (Thermo Fisher Scientific) for APEX1 (Hs00959050_g1),
BRCA1 (Hs01556193_m1), RPA1 (Hs00161419_m1), RPA3
(Hs01047933_g1), TET1 (Hs04189344_g1), TET2 (Hs00325999_m1),
hTERT (Hs00972656_m1), POU5F1 (Hs00742896_s1), SOX2
(Hs01053049_s1),MYC (Hs00153408_m1), NANOG (Hs04260366_g1), KLF-
4 (Hs00358836_m1), LIN28A (Hs00702808_s1), DNMT1 (Hs00945875_m1),
DNMT3B (Hs00171876_m1), DNMT3A (Hs01027162_m1) and DNMT3L
(Hs01081364_m1). Endogenous housekeeping genes used were ACTB
(Hs99999903_m1) and PPIA (Hs99999904_m1). All mRNA gene
expression experiments were conducted using 50 ng of cDNA per
experiment. MicroRNA was extracted using the TaqMan® microRNA
Cells-to-CT kit (Thermo Fisher Scientific). cDNA templates for miRNAs
were created using the TaqMan® Advanced miRNA cDNA synthesis kit
(Thermo Fisher Scientific) according to the manufacturer’s protocol.
TaqMan advanced miRNA assays (Thermo Fisher Scientific) used were
miR-29a-3p (478587_mir), miR-29b-3p (478369_mir) and miR-29c-3p
(479229_mir). The endogenous miRNA control was miR-361-5p
(478056_mir). All quantitative RT-PCR experiments were conducted with
a StepOnePlus Real-Time PCR System (Applied Biosystems). mRNA gene
expression and miRNA expression analysis was conducted using the
TaqMan® fast advanced master mix (Life Technologies). Graphical
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representation of gene expression in HD-affected cells is relative to the mean
expression of triplicate samples of two unaffected wild-type cell lines (as
described in the cell lines and culture section). Relative fold-changes were
calculated using the 2−ΔΔCt method. Significance was determined using a
one-way analysis of variance with a Dunnett’s post hoc test. All experiments
were independently conducted in triplicate.
Immunofluorescence imaging and quantitation
All immunofluorescence of cells was conducted on Lab-Tek microscope
chamber slides at densities of 1.5×103–5.0×103 cells/cm2. All NSC were
plated onto Geltrex-coated slides and allowed to attach for 48–72 h. Cells
were fixed with 10% NBF for 1 h, permeabilized with 100% ice-cold
methanol for 15 min at −20°C, and blocked with 10% goat serum in Tris-
buffered saline at room temperature for 1 h. To confirm successful NSC
differentiation, cells were probed with antibodies for nestin (10C2, 1:100,
Thermo Fisher Scientific), PAX6 (13B10-1A10, 1:200, Thermo Fisher
Scientific), SOX1 (ab87775, 1:200, ABCAM, Cambridge, MA) and SOX2
(PA1-094, 1:100, Thermo Fisher Scientific). Primary antibodies for TET
expression were against TET1 (GT1462, 1:500, Thermo Fisher Scientific)
and TET2 (ab94580, 10 µg/ml, Abcam). Mouse antibodies were detected
with goat anti-mouse-IgG conjugated to Alexa Fluor 488 (1:1000), and
rabbit antibodies were detected with goat anti-rabbit-IgG conjugated to
Alexa Fluor 568 (1:1000) (Thermo Fisher Scientific) for 1 h at room
temperature. All samples were counterstained with DAPI. Fluorescent
images were acquired with a Zeiss Axio Observer.Z1 microscope (Carl
Zeiss AG, Jena, Germany) with either 10× or 20× objectives. ImageJ
software version 1.51p FIJI (National Institutes of Health, Bethesda, MD;
http://imagej.nih.gov/ij) was used to determine fluorescence quantitation. At
least five images from each slide sample were acquired for relative
quantitation measurements. Cell fluorescence was determined by
multiplying the total area of the image by mean background of the
image, which was then subtracted from the integrated density. The cell
fluorescence of each image was divided by the number of complete nuclei
within the image to acquire the corrected total cell fluorescence (CTCF).
Mean CTCF is represented graphically as relative values normalized to the
mean for the Wt cells. Statistical analysis was conducted using the
Wilcoxon rank sum test of the relative fold changes.
Western blot analysis
For protein extraction, passage-matched unaffected Wt and HD-affected
NSCs were homogenized in RIPA buffer supplemented with protease
inhibitor cocktail (10 µg/ml, Sigma Aldrich). The sample was then
centrifuged at 12,000 g and the supernatant was collected for analysis.
Protein extracts were quantified using a bicinchoninic acid kit (Thermo
Fisher Scientific). Samples were diluted accordingly in RIPA buffer to
achieve similar concentrations. A total of 20 µg of protein was mixed with
Laemmli loading buffer and electrophoresed on a 7.5% Tris/glycine/SDS
polyacrylamide gel at 150 V for 45 min. Samples were transferred onto
polyvinylidine fluoride membranes (Bio-Rad). Membranes were probed
with primary antibodies against TET1 (GT1462, 1:1000, Thermo Fisher
Scientific), TET2 (P411, 1:1500, Thermo Fisher Scientific) and ACTB
(ab8224, 1 µg/ml, ABCAM) overnight at 4°C and resolved using the
VECTASTAIN ABC-AmP kit (Vector Laboratories, Burlingame, CA)
according to the manufacturer’s protocol. Immunoreactive protein bands
were imaged using a myECL Imager (Thermo Fisher Scientific) and
quantified by optical densitometry using ImageJ software (NIH). Protein
quantities were normalized to ACTB. Data is expressed as the mean±s.d.
Statistical analysis was conducted with a one-way ANOVAwith a post hoc
Tukey’s test between groups using GraphPad Prism 7.03.
TET knockdown using siRNA
To evaluate the direct link between TET expression and expression of select
DNA repair genes, 2.5×104 cells from early passage NSCs were plated onto
a 12-well plate. Upon reaching 40–60% confluency, 6 pmol of Silencer
Select Pre-designed siRNA (Thermo Fisher Scientific) for TET1 (Ambion;
ID: n368212) or TET2 siRNA (Ambion; ID: s29441) or scrambled
(Ambion; ID: 4390843) was introduced into cultures using Lipofectamine®
RNAiMAX Transfection Reagent (Thermo Fisher Scientific) according to
the manufacturer’s protocol. All experimental variations were completed
with n=4. After 72 h, cells were harvested, and RNA was extracted and
purified and transcribed into cDNA as described above. Statistical analysis
was conducted with a one-way ANOVA with a post hoc Tukey’s test
between groups using GraphPad Prism 7.03.
Fragment analysis and triplet-repeat primed PCR
Determination of HTT gene expansion was conducted using triplet-repeat
primed PCR in conjunction with capillary electrophoresis fragment
analysis (Mollica et al., 2016). Briefly, in-house designed primers were
synthesized by Integrated DNA Technologies (Coralville, IA). The forward
primer was 5′-ATGAAGGCCTTCGAGTCCCTCAAGTC-3′ with a
carboxyfluorescein at its 5′ end, and the reverse primer was 5′-
CGGTGGCGGCTGTTGCTGCTGCTGCTGCTG-3′ (Jama et al., 2013).
The repetitive (CTG) sequence at the 3′ end of the reverse primer allowed for
non-specific binding of the primer, while the 5′ end specificity ensures
complete amplification of only the gene-specific sequence. Amplification of
50 ng of gDNA was conducted using Platinum™ Taq DNA Polymerase
High Fidelity (Invitrogen). A complete PCR consisted of 1× high-fidelity
PCR buffer, 2.0 mM MgSO4, 2.0 mM betaine (Sigma Aldrich), 0.2 mM
dNTP mix, 0.2 µM of each primer, 1 U Platinum® Taq DNA Polymerase,
with sterile water up to 25 µl. PCR conditions were as follows: 94.0°C for a
1-min initial denaturation, followed by 35 cycles of 94.0°C for 1 min, 64.0°C
for 1 min, 72.0°C for 2 min, and a final extension at 72.0°C for 15 min. A 1 µl
sample of each reaction was combined with 9.0 µl of Hi-Di formamide (Life
Technologies) and 1.0 µl of Mapmarker 1000 X-Rhodamine-labeled internal
size standard (BioVentures Inc., Murfreesboro, TN) in a thin-walled 0.2 ml
PCR tube. Samples were heated to 95.0°C for 2 min to denature the
amplicons, and then immediately placed onto ice for 10 min. Capillary
electrophoresis was conducted on an Applied Biosystems 3130 Genetic
Analyzer with 50-cm arrays and POP-6 Polymer (Applied Biosystems).
Electrokinetic injection of samples was initiated with 1.6 kV for 15 s, and
then resolved at 15 kV for 2000 s at 60.0°C. Raw data were analyzed using
GeneMarker software version 2.6.7 (SoftGenetics LLC, State College, PA)
(Jama et al., 2013). Macros for sample binning were customized using six
HD-affected and unaffected, homozygous and heterozygous gDNA samples
obtained from Coriell Cell Repositories.
5-hydroxymethylcytosine detection
Relative levels of 5-hmC was detected in passage-identical cell types from
unaffected Wt cell lines and HD-affected cell lines. Global detection was
completed using the Quest 5-hmC™ DNA ELISA kit (Zymo Research,
Irvine, CA; D5426) according to the supplied protocol. Diluted anti-5-
hydroxymethylcytosine polyclonal antibody (1 ng/µl) was used to coat the
plate and allowed to incubate at 37°C for 1 h. After incubation, each well was
washed twice with 1× ELISA buffer, and then allowed to remain for 30 min.
gDNA was diluted to 50 ng/µl in 1× ELISA buffer, denatured at 98.0°C for
5 min, and then immediately placed onto ice for 10 min. DNA was further
diluted to 1 ng/µl in buffer. A total of 100 µl of dilute gDNAwas placed into
wells and incubated at 37°C for 1 h. Following incubation and successive
washes, anti-DNA horseradish peroxidase-conjugated antibody (Zymo
Research, Irvine, CA; A4001-25, 1:100) was added for 30 min. Each well
was thenwashed four times, and developer was added at room temperature for
30 min. Absorbance at 405 nm was detected using a SpectraMax i3 Multi-
Mode Detection System microplate reader (Molecular Devices, Sunnyvale,
CA). Each samplewas run in quadruplicate. Data represented is the mean±s.d.
percentage (%) 5-hmC, relative to five sets of control DNA supplied with
the assay. Statistical analysis was conducted with a one-way ANOVAwith a
post hoc Turkey’s test between groups using GraphPad Prism 7.03.
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